Literature DB >> 12843270

Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.

Jay P McLaughlin1, Monica Marton-Popovici, Charles Chavkin.   

Abstract

Previous studies have demonstrated that stress may increase prodynorphin gene expression, and kappa opioid agonists suppress drug reward. Therefore, we tested the hypothesis that stress-induced release of endogenous dynorphin may mediate behavioral responses to stress and oppose the rewarding effects of cocaine. C57Bl/6 mice subjected to repeated forced swim testing (FST) using a modified Porsolt procedure at 30 degrees C showed a characteristic stress-induced immobility response and a stress-induced analgesia observed with a tail withdrawal latency assay. Pretreatment with the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI; 10 mg/kg, i.p.) blocked the stress-induced analgesia and significantly reduced the stress-induced immobility. The nor-BNI sensitivity of the behavioral responses suggests an activation of the kappa opioid receptor by a stress-induced release of dynorphin peptides. Supporting this hypothesis, transgenic mice possessing a disrupted prodynorphin gene showed no increase in immobility or stress-induced analgesia after exposure to repeated FST. Because both stress and the kappa opioid system can modulate the response to drugs of abuse, we tested the effects of forced swim stress on cocaine-conditioned place preference (CPP). FST-exposed mice conditioned with cocaine (15 mg/kg, s.c.) showed significant potentiation of place preference for the drug-paired chamber over the responses of unstressed mice. Surprisingly, nor-BNI pretreatment blocked stress-induced potentiation of cocaine CPP. Consistent with this result, mice lacking the prodynorphin gene did not show a stress-induced potentiation of cocaine CPP, whereas wild-type littermates did. The findings suggest that chronic swim stress may activate the kappa opioid system to produce analgesia, immobility, and potentiation of the acute rewarding properties of cocaine in C57Bl/6 mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843270      PMCID: PMC2104777     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  50 in total

1.  Enhanced acquisition of cocaine self-administration in adult rats with neonatal isolation stress experience.

Authors:  T A Kosten; M J Miserendino; P Kehoe
Journal:  Brain Res       Date:  2000-09-01       Impact factor: 3.252

2.  Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice.

Authors:  I Lucki; A Dalvi; A J Mayorga
Journal:  Psychopharmacology (Berl)       Date:  2001-05       Impact factor: 4.530

3.  Generation of dynorphin knockout mice.

Authors:  N Sharifi; N Diehl; L Yaswen; M B Brennan; U Hochgeschwender
Journal:  Brain Res Mol Brain Res       Date:  2001-01-31

4.  Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats.

Authors:  Daniel C Broom; Emily M Jutkiewicz; John E Folk; John R Traynor; Kenner C Rice; James H Woods
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

5.  Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats.

Authors:  C N Haile; T GrandPre; T A Kosten
Journal:  Psychopharmacology (Berl)       Date:  2001-03-01       Impact factor: 4.530

6.  Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior.

Authors:  M Kabbaj; C S Norton; S Kollack-Walker; S J Watson; T E Robinson; H Akil
Journal:  Psychopharmacology (Berl)       Date:  2001-11-01       Impact factor: 4.530

7.  Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens.

Authors:  A M Pliakas; R R Carlson; R L Neve; C Konradi; E J Nestler; W A Carlezon
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

8.  Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade.

Authors:  Pascal Romieu; Vân Ly Phan; Rémi Martin-Fardon; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2002-04       Impact factor: 7.853

9.  Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphans.

Authors:  James B Thomas; Robert N Atkinson; Nivedita Namdev; Richard B Rothman; Kenneth M Gigstad; Scott E Fix; S Wayne Mascarella; Jason P Burgess; N Ariane Vinson; Heng Xu; Christina M Dersch; Buddy E Cantrell; Dennis M Zimmerman; F Ivy Carroll
Journal:  J Med Chem       Date:  2002-08-01       Impact factor: 7.446

10.  Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.

Authors:  J B Acri; A C Thompson; T Shippenberg
Journal:  Synapse       Date:  2001-03-15       Impact factor: 2.562

View more
  249 in total

1.  Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus neurons: linking limbic and arousal centers.

Authors:  B A S Reyes; A F Carvalho; K Vakharia; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2011-04-16       Impact factor: 5.330

2.  Long-term effects of neonatal stress on adult conditioned place preference (CPP) and hippocampal neurogenesis.

Authors:  Sarah L Hays; Ronald J McPherson; Sandra E Juul; Gerard Wallace; Abigail G Schindler; Charles Chavkin; Christine A Gleason
Journal:  Behav Brain Res       Date:  2011-10-28       Impact factor: 3.332

3.  Loss of environmental enrichment increases vulnerability to cocaine addiction.

Authors:  Joëlle Nader; Claudia Chauvet; Chauvet Claudia; Rana El Rawas; Laure Favot; Mohamed Jaber; Nathalie Thiriet; Marcello Solinas
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

Review 4.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

5.  Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats.

Authors:  Patrick M Beardsley; Gerald T Pollard; James L Howard; F Ivy Carroll
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

6.  The therapeutic potential of κ-opioids for treatment of pain and addiction.

Authors:  Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

7.  Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.

Authors:  Stephanie L Grella; Douglas Funk; Kathy Coen; Zhaoxia Li; A D Lê
Journal:  Behav Brain Res       Date:  2014-02-28       Impact factor: 3.332

8.  Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.

Authors:  Angela Henderson-Redmond; Cristine Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

9.  The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.

Authors:  Jane V Aldrich; Sanjeewa N Senadheera; Nicolette C Ross; Michelle L Ganno; Shainnel O Eans; Jay P McLaughlin
Journal:  J Nat Prod       Date:  2013-01-17       Impact factor: 4.050

Review 10.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.